Madeddu, C., Dessi, M., Panzone, F., Serpe, R., Antoni, G., Cau, M
The successful process validation and preliminary stability data represents a viable pathway for generic manufacturers to achieve bioequivalence, improving manufacturability and patient accessibility
This article was sponsored by Biosense Webster Putting the patient at the centre of the discussion is vital to setting the right strategy for the treatment of atrial fibrillation (AF)
The Lirag group was administered liraglutide (Novo Nordisk, Copenhagen, Denmark) at a dose of 200 g/kg/12 h for 8 weeks, as previously described (Hayes et al., 2011)
& Desnuelle P., 1968
Ozempic for Weight Loss Like most GLP-1 receptor agonists, both Bydureon BCise and Ozempic are associated with healthy weight loss in combination with lifestyle changes such as regular exercise and a healthy diet